NASH: The Next Big, Fatty Drug for the Pharmaceutical Industry
May 9, 2019
No Comments
With a global market estimated at $35 billion, developing a drug to treat a form of fatty liver disease called non-alcoholic steatohepatitis or NASH could be the next big thing for the pharmaceutical industry. Attention